LINDSEY MANGUM: Open Payments
NPI 1861631764 · FLORENCE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,443 in 171 payments from 24 companies in 2025. Trend: 2023 $17,549 · 2024 $7,320 · 2025 $9,443
Speaker / faculty: $6,131Food & beverage: $3,081Travel & lodging: $231
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $6,769 |
| UCB, Inc. | 21 | $412 |
| SK Life Science, Inc. | 13 | $286 |
| JAZZ PHARMACEUTICALS INC. | 12 | $246 |
| PFIZER INC. | 14 | $209 |
| Neurocrine BioSciences, Inc. | 7 | $206 |
| Biogen, Inc. | 11 | $193 |
| Lilly USA, LLC | 9 | $161 |
| Janssen Biotech, Inc. | 4 | $129 |
| ARGENX US, INC. | 4 | $113 |
Products named: QULIPTA, EPIDIOLEX, Briviact, INGREZZA, KISUNLA, NURTEC ODT, UBRELVY, Rystiggo.
Industry payments across AL — which companies pay providers there.
